Common adverse effects observed in clinical trials include nausea, vomiting, injection site reactions, increased heart rate, and hypoglycaemia risk
Side effects are rare and typically mild occasional lightheadedness, nausea, or injection site discomfort
But each type of tissue (e.g
Important Safety Note About BPC-157 BPC-157 is widely discussed for recovery and repair, but human safety data remains limited
Its this characteristic that distinguishes this peptide from the others that degrade rapidly when theyre exposed to biological environments
Pre-clinical rodent models of tendon rupture have shown combined BPC-157 and TB-500 protocols to produce faster return of tensile strength and superior histological organisation compared to either single-peptide treatment or untreated controls